Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19354 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Josine A Oud und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Autoimmunity, Erythrocytes, Erythrocyte Transfusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Leiden University Medical Center, Leids Universitair Medisch Centrum.
Abstract (Originalsprache)
Red blood cell autoimmunity and alloimmunity are potentially linked. Quantification of this association can tailor extensively matched red blood cell transfusions in patients with autoimmunity. Using an incident new‐user cohort comprising 47 285 previously non‐transfused, non‐alloimmunised patients, we compared transfusion‐induced red blood cell alloimmunisation incidences in direct antiglobulin test (DAT)‐positive and control patients. Additionally, we performed case–control analyses to handle potential confounding by clinical immunomodulators. Among (IgG and/or C3d) DAT‐positive patients ( N = 380), cumulative red blood cell alloimmunisation incidences after 10 units transfused reached 4.5% (95% confidence interval [CI] 2.5–8.2) versus 4.2% (CI 3.9–4.5, p = 0.88) in controls. In case–control analyses, alloimmunisation relative risks among DAT‐positive patients increased to 1.7 (CI 1.1–2.8). Additional adjustments for pre‐DAT transfusion exposure or the extent of Rh/K mismatching did not impact results. In conclusion, while patients with DAT positivity show an intrinsically increased alloimmune red blood cell response, their absolute risk is comparable to control patients due to counteracting co‐existing immunosuppressive conditions. Consequently, isolated DAT positivity in patients lacking overt haemolysis or complicated alloantibody testing does not seem to warrant extended matching strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Transfusion Research, Sanquin Research, Leiden, The Netherlands.
- Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Immunohaematology Diagnostics, Sanquin, Amsterdam, The Netherlands.
- Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Clinical Chemistry and Haematology, Catharina Hospital, Eindhoven, The Netherlands.
ORCID-Profile: Josine A Oud, Dorothea Evers
Förderung
- Leiden University Medical Center
- Leids Universitair Medisch Centrum
Zitieren
APA
Oud, J. A., de Haas, M., de Vooght, K. M. K., van de Kerkhof, D., Som, N., Péquériaux, N. C. V., Hudig, F., van der Bom, J. G., Evers, D., & Zwaginga, J. J. (2024). Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion. British Journal of Haematology. https://doi.org/10.1111/bjh.19354
Vancouver
Oud JA, de Haas M, de Vooght KMK, van de Kerkhof D, Som N, Péquériaux NCV, et al. Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion. British Journal of Haematology. 2024. doi:10.1111/bjh.19354
BibTeX
@article{Oud2024,
author = {Oud, Josine A and de Haas, Masja and de Vooght, Karen M K and van de Kerkhof, Daan and Som, Nel and Péquériaux, Nathalie C V and Hudig, Francisca and van der Bom, Johanna G and Evers, Dorothea and Zwaginga, Jaap Jan},
title = {Challenging the dogma: Red blood cell‐directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19354}
}
EUVIMED